How automation with AccuVax and AccuShelf protects patients and healthcare teams

Check out this recent publication in ONdrugDelivery Issue 177 authored by LTI's own Edward Trappler, Denise Miller, and Michael Thomas. This piece discusses the challenges for lyophilized products and considers the role of dual-chamber devices in simplifying reconstitution, particularly for at-home healthcare products, and goes on to look at how future advances in delivery devices are providing safe solutions for self-administration while improving patient adherence. https://lnkd.in/eSVeWhEg

Empowering Pulmonologists with Next-Gen EMR Software "Transform the way pulmonologists deliver care with Next-Gen EMR Software! 🩺💻 From faster diagnosis to improved patient engagement, this smart solution is designed to simplify workflows, ensure accuracy, and provide actionable insights for better lung health outcomes. 🚀" 𝟏.𝐒𝐭𝐫𝐞𝐚𝐦𝐥𝐢𝐧𝐞𝐝 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬: Save time with ready-to-use pulmonology templates. 𝟐.𝐄𝐧𝐡𝐚𝐧𝐜𝐞𝐝 𝐀𝐜𝐜𝐮𝐫𝐚𝐜𝐲: Seamless integration of spirometry, imaging & reports. 𝟑.𝐁𝐞𝐭𝐭𝐞𝐫 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭: Secure telehealth & remote monitoring features. 𝟒.𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬: AI-powered alerts for treatment, allergies & prescriptions. 𝟓.𝐂𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐑𝐞𝐚𝐝𝐲: ABDM & HIPAA compliant for secure health data exchange. 𝟔.𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐆𝐫𝐨𝐰𝐭𝐡: Automated billing & coding reduces claim denials. 𝟕.𝐀𝐜𝐭𝐢𝐨𝐧𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Analytics dashboard to monitor outcomes & performance. #PulmonologyCare #NextGenEMR #HealthcareInnovation #SmartClinics #DigitalHealth #PatientFirst #HealthTech #MedicalSoftware #PulmonologistTools #FutureOfHealthcare

🚀 Future-Proofing Dialysis: Building Resilient Clinics for 2026 and Beyond 🚀 The dialysis industry is on the brink of transformation. As CMS continues tightening regulations and new technologies reshape clinical operations, the question isn’t if your dialysis facility needs to evolve—it’s how quickly it can adapt. At Dialysis Policy Development, we’re helping dialysis centers nationwide strengthen compliance, streamline processes, and future-proof their operations for the next wave of change. 🔹 Top Priorities for Dialysis Facilities in 2026 1️⃣ Adapting to CMS 2026 Policy Updates New guidance for ESRD Conditions for Coverage is expected to bring increased focus on QAPI integration, infection control documentation, and emergency preparedness. Facilities that plan ahead now will be survey-ready and confident when regulations shift. 2️⃣ Building Resilient Staffing Models Turnover remains one of the biggest threats to dialysis operations. Flexible scheduling, AI-assisted workforce planning, and strong onboarding processes are no longer luxuries—they’re necessities to maintain patient continuity and quality of care. 3️⃣ Leveraging AI for Continuous Compliance AI-driven tools can now identify gaps in policy implementation, automate training reminders, and track compliance data in real time. Clinics using smart analytics see measurable gains in survey outcomes and staff efficiency. 4️⃣ Enhancing Patient Engagement and Retention Patient satisfaction is directly tied to CMS quality metrics. From mobile check-ins to telehealth follow-ups, improving communication and accessibility helps clinics reduce missed treatments and boost retention. 💡 Your Partner in Dialysis Excellence Whether your goal is to update policies, prepare for CMS audits, or improve patient care outcomes, our tailored consulting services make compliance achievable—and sustainable. 📲 Visit https://lnkd.in/eHjkhqSV to explore how we can help your clinic thrive in 2026 and beyond. #DialysisCare #DialysisPolicyDevelopment #HealthcareConsulting #RegulatoryCompliance #DialysisInnovation #CMSCompliance #DialysisConsulting #DialysisPolicies #DialysisManuals #DialysisOperations #DialysisEfficiency #ESRD #Nephrology #DialysisPoliciesAndProcedures #DialysisExcellence #HealthcareInnovation #PatientCare #DialysisBestPractices #ConsultingServices #DialysisCompliance #DialysisClinicSupport #DialysisPoliciesForPurchase

🚀 Future-Proofing Dialysis: Building Resilient Clinics for 2026 and Beyond 🚀 The dialysis industry is on the brink of transformation. As CMS continues tightening regulations and new technologies reshape clinical operations, the question isn’t if your dialysis facility needs to evolve—it’s how quickly it can adapt. At Dialysis Policy Development, we’re helping dialysis centers nationwide strengthen compliance, streamline processes, and future-proof their operations for the next wave of change. 🔹 Top Priorities for Dialysis Facilities in 2026 1️⃣ Adapting to CMS 2026 Policy Updates New guidance for ESRD Conditions for Coverage is expected to bring increased focus on QAPI integration, infection control documentation, and emergency preparedness. Facilities that plan ahead now will be survey-ready and confident when regulations shift. 2️⃣ Building Resilient Staffing Models Turnover remains one of the biggest threats to dialysis operations. Flexible scheduling, AI-assisted workforce planning, and strong onboarding processes are no longer luxuries—they’re necessities to maintain patient continuity and quality of care. 3️⃣ Leveraging AI for Continuous Compliance AI-driven tools can now identify gaps in policy implementation, automate training reminders, and track compliance data in real time. Clinics using smart analytics see measurable gains in survey outcomes and staff efficiency. 4️⃣ Enhancing Patient Engagement and Retention Patient satisfaction is directly tied to CMS quality metrics. From mobile check-ins to telehealth follow-ups, improving communication and accessibility helps clinics reduce missed treatments and boost retention. 💡 Your Partner in Dialysis Excellence Whether your goal is to update policies, prepare for CMS audits, or improve patient care outcomes, our tailored consulting services make compliance achievable—and sustainable. 📲 Visit https://lnkd.in/emDqB9t5 to explore how we can help your clinic thrive in 2026 and beyond. #DialysisCare #DialysisPolicyDevelopment #HealthcareConsulting #RegulatoryCompliance #DialysisInnovation #CMSCompliance #DialysisConsulting #DialysisPolicies #DialysisManuals #DialysisOperations #DialysisEfficiency #ESRD #Nephrology #DialysisPoliciesAndProcedures #DialysisExcellence #HealthcareInnovation #PatientCare #DialysisBestPractices #ConsultingServices #DialysisCompliance #DialysisClinicSupport #DialysisPoliciesForPurchase

Discharge planning and medication management are vital for patient recovery, but they’re often prone to inefficiencies. Technology can bridge the gaps, ensuring seamless communication, reducing errors, and supporting patients post-discharge. Learn about the the best practices and how technology plays a role in improving care transitions here: https://buff.ly/kX6b9aZ #HealthTech #EHealth #Discharge

#OnlineFirst w/ #PMT #JPharmTechnol this week, Sunshine & colleagues at Henry Ford Health in Detroit demonstrated that an interruptive EHR alert significantly improved guideline-appropriate prescribing of metronidazole to treat trichomoniasis. #antimicrobialstewardship #pharmacists https://lnkd.in/e8eNbpyW

Alert: The numbers do not reflect the reality: Medication error statistics reported by national and international agencies represent only a small fraction of the true harm caused by unsafe medication practices worldwide. In the United States, the Food and Drug Administration receives over 100,000 medication error reports each year, yet this number grossly underestimates the true prevalence of harm: research indicates that more than 7 million Americans experience some form of medication-related injury annually, with studies estimating only about 1-2% of actual incidents are reported to authorities. This dramatic underreporting mirrors global patterns, where millions of incidents every year go undocumented due to barriers such as stigma, poor infrastructure, and inconsistent surveillance systems. Underreporting limits the effectiveness of international and national patient safety initiatives. Across settings—from hospitals to home care—errors can occur during prescribing, dispensing, or administration, with many stakeholders remaining unaware or reluctant to report incidents. In some regions, well over 90% of medication errors are never formally captured in official statistics—this figure applies not only to the United States but also to Europe, Asia, and Africa, according to World Health Organization studies. Systemic barriers such as insufficient education, fear of repercussions, and lack of standardized reporting mechanisms mean that true rates of harm remain invisible in both developed and developing countries. Consequently, published figures cannot be relied upon to reflect the actual magnitude of medication-related harm. The gap between documented and real incidents highlights the urgent need for improved reporting systems, greater transparency, and widespread preventive strategies. International leadership, such as WHO’s “Medication Without Harm” initiative, targets a 50% reduction in severe medication harm over five years, a goal only attainable through global cooperation, robust data collection, and active engagement from providers, patients, and policymakers worldwide.

Partnership combines CareMetx's technology and robust data with Syneos Health's leading patient support services to streamline medication access and reduce time to therapy.

Medicines supply disruptions — particularly of off-patent antibiotics — are a worrying reality across Europe. The recommendations set out in this report provide a clear roadmap to secure patient access to essential treatments. We look forward to engaging with stakeholders to strengthen access and supply security for all patients.

Interesting news. DTP (Direct-to-Patient) programs by #Pharma are here to stay. "After surveying “every corner of the healthcare ecosystem,” according to Matt Walsh, general manager at ixlayer, the common thread appears to be “direct-to-patient solutions that feel simple and seamless for the patient, connect back to their doctor—or help them find one—and make pharma marketing initiatives more actionable, ultimately driving better health outcomes as well as commercial success,” Walsh said in a statement to Fierce Pharma Marketing."